CJC-1295 NO DAC Dosage, Protocol, and GH Optimization Guide (Mod GRF 1–29)

CJC-1295 NO DAC (Mod GRF 1–29)

CJC-1295 NO DAC (Modified GRF 1–29) is a short-acting GHRH analog that stimulates natural, pulsatile growth hormone release. Unlike DAC versions or exogenous HGH, it preserves physiologic hormone rhythms and feedback mechanisms.

How CJC-1295 NO DAC Works

GHRH Signal → Pituitary Activation → GH Pulse ↑ → IGF-1 ↑ → Recovery + Fat Loss ↑

CJC-1295 NO DAC binds to GHRH receptors in the pituitary, triggering natural GH pulses. Its short half-life (~30 minutes) mimics the body’s normal secretion pattern, making it ideal for physiologic hormone optimization.

Short-acting GHRH analog designed for pulsatile GH release.

Different from CJC-1295 DAC, which has a much longer half-life.

Often discussed with GHRPs like Ipamorelin for stronger GH pulse signaling.

Best used with consistent timing, usually fasted before bed.

CJC-1295 NO DAC Protocol

5 mg vial + 3.0 mL BAC Water → 1 unit = 16.7 mcg → Short GH Pulse Support

Standard Setup

Vial 5 mg

Water 3.0 mL bacteriostatic water

Concentration 1.67 mg/mL

Conversion 1 unit = 16.7 mcg

Weeks 1–2

Start Phase

Dose100 mcg

Units6 units

Volume0.06 mL

Weeks 3–4

Build Phase

Dose150 mcg

Units9 units

Volume0.09 mL

Weeks 5–6

Peak Phase

Dose200 mcg

Units12 units

Volume0.12 mL

Weeks 7–12

Maintain Phase

Dose250–300 mcg

Units15–18 units

Volume0.15–0.18 mL

Protocol Details

FrequencyOnce daily

Advanced Frequency2x daily

TimingBedtime, fasted ≥2 hours

Cycle Length8–12 weeks

Optional ExtensionUp to 16 weeks

Simple structure

CJC-1295 NO DAC is built around short, natural GH pulse support. Because it is short-acting, consistent timing matters more than with DAC versions.

Clinical vs Real-World Use

Key Differences

Short half-life requires consistent timing

Pulsatile GH release mimics natural physiology

Often stacked with GHRPs like Ipamorelin in research-style protocols

More timing-sensitive than long-acting DAC versions

Simple comparison:

NO DAC is better for short pulse-style GH signaling. DAC is better for convenience and smoother long-acting exposure.

How to Use CJC-1295 NO DAC (Timing & Injection)

Injection TypeSubcutaneous

TimingBefore bed

Fasted StateFasted ≥2 hours

Advanced OptionSplit AM + PM dosing

When & Where to Inject

Subcutaneous injection

Abdomen, thigh, or upper arm

Administer before bed while fasted

Optional split AM + PM dosing for advanced users

Rotate injection sites regularly

Timing Notes

Bedtime dosing is commonly used to align with nighttime recovery.

Fasted timing is preferred because food may blunt GH signaling.

Because NO DAC is short-acting, timing matters more than with CJC-1295 DAC.

Reconstitution & Dosing (5 mg Vial)

Vial5 mg

Water3.0 mL bacteriostatic

Concentration1.67 mg/mL

Conversion1 unit = 16.7 mcg

Dose Reference

6 units ≈ 100 mcg

9 units ≈ 150 mcg

12 units ≈ 200 mcg

15 units ≈ 250 mcg

18 units ≈ 300 mcg

Reconstitution Steps

Draw 3.0 mL bacteriostatic water

Inject slowly down vial wall

Gently swirl, do not shake

Allow powder to fully dissolve

Label with mix date

Refrigerate immediately

Storage & Shelf Life

Storage & Shelf Life

Lyophilized (Unmixed)

Short-term: refrigerate at 2–8°C

Long-term: freeze at −20°C / −4°F

Refrigerated shelf life: ~12–24 months when sealed and dry

Frozen shelf life: ~2–3 years when stored properly

Keep sealed, dry, and protected from light

Avoid moisture, heat, sunlight, and repeated temperature changes

Do not repeatedly freeze and thaw the same vial

Reconstituted (Mixed)

Refrigerate at 2–8°C

Use within 7–14 days

Do not freeze after mixing

Discard if cloudy, discolored, or if particles appear

Important storage note

CJC-1295 NO DAC is short-acting and more delicate once mixed. Keep reconstituted peptide cold and use it within a shorter window than many longer-acting peptides.

Cycle Length & Time Between Cycles

Pulse GH Phase → Break → Reassess IGF-1 + Recovery → Repeat if Needed

Cycle Structure

Cycle Length8–12 weeks

Optional ExtensionUp to 16 weeks

GoalPulsatile GH + IGF-1 support

Time Between Cycles

Break2–4 weeks

Allows GH signaling to reset

Helps maintain responsiveness

Gives time to reassess sleep, recovery, and IGF-1 response

Why cycle?

Cycling helps preserve responsiveness and prevents long-term use from becoming routine without reassessing whether sleep, recovery, body composition, or IGF-1 markers are actually improving.

Monitoring During Use

IGF-1 levels, primary marker

Sleep quality

Recovery and soreness

Body composition changes

Water retention or flushing

Benefits

Stimulates natural GH release

Increases IGF-1 levels

Improves recovery and sleep

Supports fat loss and lean mass

Maintains physiologic hormone balance

Potential Side Effects

Injection site irritation

Mild flushing

Headache, rare

Temporary water retention, mild

Stacking Strategies

Short GH Pulse → GHRP Pairing → Recovery + Composition Support

GH Optimization: CJC-1295 NO DAC + Ipamorelin

Fat Loss: CJC-1295 + AOD-9604

Recovery: CJC-1295 + BPC-157

Stacking note

CJC-1295 NO DAC is commonly paired with a GHRP because one compound supports the GHRH side and the other supports ghrelin receptor signaling.

Important Notes

Short half-life requires consistent dosing

Works best fasted

Requires functional pituitary response

More physiologic than exogenous GH

More timing-sensitive than CJC-1295 DAC

Important Disclaimer

CJC-1295 NO DAC is not FDA-approved. This content is for educational purposes only.

CJC-1295 No DAC Guide → Peptide Directory →